APO Research
Talk to an analyst

APO RESEARCH · REPORT

Macrolide Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Macrolide Drugs Industry Growth and Trends Forecast to 2032

22 December 2025113 pages

Choose your research edition.

Industry ResearchMacrolide Drugs Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Macrolide Drugs Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Macrolide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Macrolide Drugs Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Macrolide Drugs Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Macrolide Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Macrolide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Macrolide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Macrolide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Macrolide Drugs include Teva Pharmaceutical Industries, Sanofi, Merck & Co., Mylan, Pfizer, Fresenius Kabi, WOCKHARDT, Tacorolimus and Sirolimus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Macrolide Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Macrolide Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Macrolide Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Macrolide Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Macrolide Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Macrolide Drugs Market by Company

Teva Pharmaceutical Industries

Sanofi

Merck & Co.

Mylan

Pfizer

Fresenius Kabi

WOCKHARDT

Tacorolimus

Sirolimus

Sandoz International

Neo Química

Macrolide Pharmaceuticals

Gland Pharmm

Eli Lilly & Co.

Akorn

Abbott Laboratories

Macrolide Drugs Segment by Type

14-Membered Ring Agents

15-Membered Ring Agents

16-Membered Ring Agents

Ketolides

Macrolide Drugs Segment by Application

Clinics

Hospitalshospital Pharmacies

Hospitals

Online Pharmacies

Retail Pharmacies

Macrolide Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Macrolide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Macrolide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Macrolide Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Macrolide Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Macrolide Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 14-Membered Ring Agents Table 2. Major Company of 15-Membered Ring Agents Table 3. Major Company of 16-Membered Ring Agents Table 4. Major Company of Ketolides Table 5. Global Macrolide Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Macrolide Drugs Sales by Type (2021-2026) & (k units) Table 7. Global Macrolide Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Macrolide Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Macrolide Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Macrolide Drugs Price by Type (2021-2026) & (US$/unit) Table 11. Global Macrolide Drugs Sales by Type (2027-2032) & (k units) Table 12. Global Macrolide Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Macrolide Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Macrolide Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Macrolide Drugs Price by Type (2027-2032) & (US$/unit) Table 16. North America Macrolide Drugs Sales by Type (2021-2026) & (k units) Table 17. North America Macrolide Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Macrolide Drugs Sales by Type (2021-2026) & (k units) Table 19. Europe Macrolide Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Macrolide Drugs Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Macrolide Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Macrolide Drugs Sales by Type (2021-2026) & (k units) Table 23. Latin America Macrolide Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Macrolide Drugs Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Macrolide Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Macrolide Drugs Industry Trends Table 27. Macrolide Drugs Industry Drivers Table 28. Macrolide Drugs Industry Opportunities and Challenges Table 29. Macrolide Drugs Industry Restraints Table 30. Global Macrolide Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Macrolide Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Macrolide Drugs Sales by Company (2021-2026) & (k units) Table 33. Global Macrolide Drugs Sales Share by Company (2021-2026) Table 34. Global Macrolide Drugs Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Macrolide Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Macrolide Drugs Major Company Production Sites and Headquarters Table 37. Global Macrolide Drugs Company, Product Type & Application Table 38. Global Macrolide Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Macrolide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Macrolide Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Macrolide Drugs Sales by Region (2021-2026) & (k units) Table 43. Global Macrolide Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Macrolide Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Macrolide Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Macrolide Drugs Sales by Region (2027-2032) & (k units) Table 48. Global Macrolide Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Macrolide Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Macrolide Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Macrolide Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Macrolide Drugs Sales by Application (2021-2026) & (k units) Table 54. Global Macrolide Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Macrolide Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Macrolide Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Macrolide Drugs Price by Application (2021-2026) & (US$/unit) Table 58. Global Macrolide Drugs Sales by Application (2027-2032) & (k units) Table 59. Global Macrolide Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Macrolide Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Macrolide Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Macrolide Drugs Price by Application (2027-2032) & (US$/unit) Table 63. North America Macrolide Drugs Sales by Application (2021-2026) & (k units) Table 64. North America Macrolide Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Macrolide Drugs Sales by Application (2021-2026) & (k units) Table 66. Europe Macrolide Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Macrolide Drugs Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Macrolide Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Macrolide Drugs Sales by Application (2021-2026) & (k units) Table 70. Latin America Macrolide Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Macrolide Drugs Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Macrolide Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Pharmaceutical Industries Company Information Table 74. Teva Pharmaceutical Industries Business Overview Table 75. Teva Pharmaceutical Industries Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Industries Macrolide Drugs Product Portfolio Table 77. Teva Pharmaceutical Industries Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Sanofi Macrolide Drugs Product Portfolio Table 82. Sanofi Recent Development Table 83. Merck & Co. Company Information Table 84. Merck & Co. Business Overview Table 85. Merck & Co. Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Merck & Co. Macrolide Drugs Product Portfolio Table 87. Merck & Co. Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Mylan Macrolide Drugs Product Portfolio Table 92. Mylan Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Pfizer Macrolide Drugs Product Portfolio Table 97. Pfizer Recent Development Table 98. Fresenius Kabi Company Information Table 99. Fresenius Kabi Business Overview Table 100. Fresenius Kabi Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Fresenius Kabi Macrolide Drugs Product Portfolio Table 102. Fresenius Kabi Recent Development Table 103. WOCKHARDT Company Information Table 104. WOCKHARDT Business Overview Table 105. WOCKHARDT Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. WOCKHARDT Macrolide Drugs Product Portfolio Table 107. WOCKHARDT Recent Development Table 108. Tacorolimus Company Information Table 109. Tacorolimus Business Overview Table 110. Tacorolimus Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Tacorolimus Macrolide Drugs Product Portfolio Table 112. Tacorolimus Recent Development Table 113. Sirolimus Company Information Table 114. Sirolimus Business Overview Table 115. Sirolimus Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Sirolimus Macrolide Drugs Product Portfolio Table 117. Sirolimus Recent Development Table 118. Sandoz International Company Information Table 119. Sandoz International Business Overview Table 120. Sandoz International Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Sandoz International Macrolide Drugs Product Portfolio Table 122. Sandoz International Recent Development Table 123. Neo Química Company Information Table 124. Neo Química Business Overview Table 125. Neo Química Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Neo Química Macrolide Drugs Product Portfolio Table 127. Neo Química Recent Development Table 128. Macrolide Pharmaceuticals Company Information Table 129. Macrolide Pharmaceuticals Business Overview Table 130. Macrolide Pharmaceuticals Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Macrolide Pharmaceuticals Macrolide Drugs Product Portfolio Table 132. Macrolide Pharmaceuticals Recent Development Table 133. Gland Pharmm Company Information Table 134. Gland Pharmm Business Overview Table 135. Gland Pharmm Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Gland Pharmm Macrolide Drugs Product Portfolio Table 137. Gland Pharmm Recent Development Table 138. Eli Lilly & Co. Company Information Table 139. Eli Lilly & Co. Business Overview Table 140. Eli Lilly & Co. Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Eli Lilly & Co. Macrolide Drugs Product Portfolio Table 142. Eli Lilly & Co. Recent Development Table 143. Akorn Company Information Table 144. Akorn Business Overview Table 145. Akorn Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Akorn Macrolide Drugs Product Portfolio Table 147. Akorn Recent Development Table 148. Abbott Laboratories Company Information Table 149. Abbott Laboratories Business Overview Table 150. Abbott Laboratories Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 151. Abbott Laboratories Macrolide Drugs Product Portfolio Table 152. Abbott Laboratories Recent Development Table 153. North America Macrolide Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. North America Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 155. North America Macrolide Drugs Sales Market Share by Country (2021-2026) Table 156. North America Macrolide Drugs Sales Forecast by Country (2027-2032) & (k units) Table 157. North America Macrolide Drugs Sales Market Share Forecast by Country (2027-2032) Table 158. North America Macrolide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Macrolide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Macrolide Drugs Market Share by Country (2021-2026) Table 161. North America Macrolide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Macrolide Drugs Market Share Forecast by Country (2027-2032) Table 163. Europe Macrolide Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 164. Europe Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 165. Europe Macrolide Drugs Sales Market Share by Country (2021-2026) Table 166. Europe Macrolide Drugs Sales Forecast by Country (2027-2032) & (k units) Table 167. Europe Macrolide Drugs Sales Market Share Forecast by Country (2027-2032) Table 168. Europe Macrolide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Macrolide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Macrolide Drugs Market Share by Country (2021-2026) Table 171. Europe Macrolide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Macrolide Drugs Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Macrolide Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 175. Asia-Pacific Macrolide Drugs Sales Market Share by Country (2021-2026) Table 176. Asia-Pacific Macrolide Drugs Sales Forecast by Country (2027-2032) & (k units) Table 177. Asia-Pacific Macrolide Drugs Sales Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Macrolide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Macrolide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Macrolide Drugs Market Share by Country (2021-2026) Table 181. Asia-Pacific Macrolide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Macrolide Drugs Market Share Forecast by Country (2027-2032) Table 183. Latin America Macrolide Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 184. Latin America Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 185. Latin America Macrolide Drugs Sales Market Share by Country (2021-2026) Table 186. Latin America Macrolide Drugs Sales Forecast by Country (2027-2032) & (k units) Table 187. Latin America Macrolide Drugs Sales Market Share Forecast by Country (2027-2032) Table 188. Latin America Macrolide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Macrolide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Macrolide Drugs Market Share by Country (2021-2026) Table 191. Latin America Macrolide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Macrolide Drugs Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Macrolide Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 195. Middle East and Africa Macrolide Drugs Sales Market Share by Country (2021-2026) Table 196. Middle East and Africa Macrolide Drugs Sales Forecast by Country (2027-2032) & (k units) Table 197. Middle East and Africa Macrolide Drugs Sales Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Macrolide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Macrolide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East and Africa Macrolide Drugs Market Share by Country (2021-2026) Table 201. Middle East and Africa Macrolide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East and Africa Macrolide Drugs Market Share Forecast by Country (2027-2032) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Macrolide Drugs Distributors List Table 206. Macrolide Drugs Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Macrolide Drugs Image Figure 2. Global Macrolide Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Macrolide Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Macrolide Drugs Sales (2021-2032) & (k units) Figure 5. 14-Membered Ring Agents Image Figure 6. Global 14-Membered Ring Agents Sales YoY Growth (2021-2032) & (k units) Figure 7. 15-Membered Ring Agents Image Figure 8. Global 15-Membered Ring Agents Sales YoY Growth (2021-2032) & (k units) Figure 9. 16-Membered Ring Agents Image Figure 10. Global 16-Membered Ring Agents Sales YoY Growth (2021-2032) & (k units) Figure 11. Ketolides Image Figure 12. Global Ketolides Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Macrolide Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Macrolide Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Macrolide Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Macrolide Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Macrolide Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Macrolide Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Macrolide Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Macrolide Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Macrolide Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Macrolide Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Macrolide Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Macrolide Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Macrolide Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 29. Hospitalshospital Pharmacies Image Figure 30. Global Hospitalshospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospitals Image Figure 32. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 33. Online Pharmacies Image Figure 34. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 35. Retail Pharmacies Image Figure 36. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Macrolide Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Macrolide Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Macrolide Drugs Sales Market Share in Volume by Application in 2025 Figure 40. North America Macrolide Drugs Sales Market Share in Value by Application in 2025 Figure 41. Europe Macrolide Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Europe Macrolide Drugs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Macrolide Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Macrolide Drugs Sales Market Share in Value by Application in 2025 Figure 45. Latin America Macrolide Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Macrolide Drugs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Macrolide Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Macrolide Drugs Sales Market Share in Value by Application in 2025 Figure 49. North America Macrolide Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Macrolide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Macrolide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Macrolide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Macrolide Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Macrolide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Macrolide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Macrolide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Macrolide Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Macrolide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Macrolide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Macrolide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Macrolide Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Macrolide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Macrolide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Macrolide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Macrolide Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Macrolide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Macrolide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Macrolide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Macrolide Drugs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Macrolide Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • 14-Membered Ring Agents
  • 15-Membered Ring Agents
  • 16-Membered Ring Agents
  • Ketolides
Applications
  • Clinics
  • Hospitalshospital Pharmacies
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Teva Pharmaceutical Industries
  • Sanofi
  • Merck & Co.
  • Mylan
  • Pfizer
  • Fresenius Kabi
  • WOCKHARDT
  • Tacorolimus
  • Sirolimus
  • Sandoz International
  • Neo Química
  • Macrolide Pharmaceuticals
  • Gland Pharmm
  • Eli Lilly & Co.
  • Akorn
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Macrolide Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Macrolide Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Macrolide Drugs Market by Type
  6. 1.3.1 14-Membered Ring Agents
  7. 1.3.2 15-Membered Ring Agents
  8. 1.3.3 16-Membered Ring Agents
  9. 1.3.4 Ketolides
  10. 1.4 Global Macrolide Drugs Market Size by Type
  11. 1.4.1 Global Macrolide Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Macrolide Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Macrolide Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Macrolide Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Macrolide Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Macrolide Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Macrolide Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Macrolide Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Macrolide Drugs Industry Trends
  2. 2.2 Macrolide Drugs Industry Drivers
  3. 2.3 Macrolide Drugs Industry Opportunities and Challenges
  4. 2.4 Macrolide Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Macrolide Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Macrolide Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Macrolide Drugs Price (2021-2026)
  4. 3.4 Global Macrolide Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Macrolide Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Macrolide Drugs Company, Product Type & Application
  7. 3.7 Global Macrolide Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Macrolide Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Macrolide Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Macrolide Drugs Tier 1, Tier 2, and Tier 3
4 Macrolide Drugs Regional Status and Outlook
  1. 4.1 Global Macrolide Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Macrolide Drugs Historic Market Size by Region
  3. 4.2.1 Global Macrolide Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Macrolide Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Macrolide Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Macrolide Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Macrolide Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Macrolide Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Macrolide Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Macrolide Drugs by Application
  1. 5.1 Macrolide Drugs Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitalshospital Pharmacies
  4. 5.1.3 Hospitals
  5. 5.1.4 Online Pharmacies
  6. 5.1.5 Retail Pharmacies
  7. 5.2 Global Macrolide Drugs Market Size by Application
  8. 5.2.1 Global Macrolide Drugs Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Macrolide Drugs Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Macrolide Drugs Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Macrolide Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Macrolide Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Macrolide Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Macrolide Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Macrolide Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Macrolide Drugs Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Macrolide Drugs Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Merck & Co.
  14. 6.3.1 Merck & Co. Company Information
  15. 6.3.2 Merck & Co. Business Overview
  16. 6.3.3 Merck & Co. Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck & Co. Macrolide Drugs Product Portfolio
  18. 6.3.5 Merck & Co. Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Macrolide Drugs Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Macrolide Drugs Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Fresenius Kabi
  32. 6.6.1 Fresenius Kabi Company Information
  33. 6.6.2 Fresenius Kabi Business Overview
  34. 6.6.3 Fresenius Kabi Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fresenius Kabi Macrolide Drugs Product Portfolio
  36. 6.6.5 Fresenius Kabi Recent Developments
  37. 6.7 WOCKHARDT
  38. 6.7.1 WOCKHARDT Company Information
  39. 6.7.2 WOCKHARDT Business Overview
  40. 6.7.3 WOCKHARDT Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 WOCKHARDT Macrolide Drugs Product Portfolio
  42. 6.7.5 WOCKHARDT Recent Developments
  43. 6.8 Tacorolimus
  44. 6.8.1 Tacorolimus Company Information
  45. 6.8.2 Tacorolimus Business Overview
  46. 6.8.3 Tacorolimus Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Tacorolimus Macrolide Drugs Product Portfolio
  48. 6.8.5 Tacorolimus Recent Developments
  49. 6.9 Sirolimus
  50. 6.9.1 Sirolimus Company Information
  51. 6.9.2 Sirolimus Business Overview
  52. 6.9.3 Sirolimus Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sirolimus Macrolide Drugs Product Portfolio
  54. 6.9.5 Sirolimus Recent Developments
  55. 6.10 Sandoz International
  56. 6.10.1 Sandoz International Company Information
  57. 6.10.2 Sandoz International Business Overview
  58. 6.10.3 Sandoz International Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sandoz International Macrolide Drugs Product Portfolio
  60. 6.10.5 Sandoz International Recent Developments
  61. 6.11 Neo Química
  62. 6.11.1 Neo Química Company Information
  63. 6.11.2 Neo Química Business Overview
  64. 6.11.3 Neo Química Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Neo Química Macrolide Drugs Product Portfolio
  66. 6.11.5 Neo Química Recent Developments
  67. 6.12 Macrolide Pharmaceuticals
  68. 6.12.1 Macrolide Pharmaceuticals Company Information
  69. 6.12.2 Macrolide Pharmaceuticals Business Overview
  70. 6.12.3 Macrolide Pharmaceuticals Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Macrolide Pharmaceuticals Macrolide Drugs Product Portfolio
  72. 6.12.5 Macrolide Pharmaceuticals Recent Developments
  73. 6.13 Gland Pharmm
  74. 6.13.1 Gland Pharmm Company Information
  75. 6.13.2 Gland Pharmm Business Overview
  76. 6.13.3 Gland Pharmm Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Gland Pharmm Macrolide Drugs Product Portfolio
  78. 6.13.5 Gland Pharmm Recent Developments
  79. 6.14 Eli Lilly & Co.
  80. 6.14.1 Eli Lilly & Co. Company Information
  81. 6.14.2 Eli Lilly & Co. Business Overview
  82. 6.14.3 Eli Lilly & Co. Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Eli Lilly & Co. Macrolide Drugs Product Portfolio
  84. 6.14.5 Eli Lilly & Co. Recent Developments
  85. 6.15 Akorn
  86. 6.15.1 Akorn Company Information
  87. 6.15.2 Akorn Business Overview
  88. 6.15.3 Akorn Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Akorn Macrolide Drugs Product Portfolio
  90. 6.15.5 Akorn Recent Developments
  91. 6.16 Abbott Laboratories
  92. 6.16.1 Abbott Laboratories Company Information
  93. 6.16.2 Abbott Laboratories Business Overview
  94. 6.16.3 Abbott Laboratories Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Abbott Laboratories Macrolide Drugs Product Portfolio
  96. 6.16.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Macrolide Drugs Sales by Country
  2. 7.1.1 North America Macrolide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Macrolide Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Macrolide Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Macrolide Drugs Market Size by Country
  6. 7.2.1 North America Macrolide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Macrolide Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Macrolide Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Macrolide Drugs Sales by Country
  2. 8.1.1 Europe Macrolide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Macrolide Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Macrolide Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Macrolide Drugs Market Size by Country
  6. 8.2.1 Europe Macrolide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Macrolide Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Macrolide Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Macrolide Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Macrolide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Macrolide Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Macrolide Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Macrolide Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Macrolide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Macrolide Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Macrolide Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Macrolide Drugs Sales by Country
  2. 10.1.1 South America Macrolide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Macrolide Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Macrolide Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Macrolide Drugs Market Size by Country
  6. 10.2.1 South America Macrolide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Macrolide Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Macrolide Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Macrolide Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Macrolide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Macrolide Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Macrolide Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Macrolide Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Macrolide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Macrolide Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Macrolide Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Macrolide Drugs Value Chain Analysis
  2. 12.1.1 Macrolide Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Macrolide Drugs Production Mode & Process
  7. 12.2 Macrolide Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Macrolide Drugs Distributors
  10. 12.2.3 Macrolide Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst